More Sun Pharmaceutical Industries Limited news
Sun Pharmaceutical Industries LimitedNSE: SUNPHARMA

Press Release Apr 24 2025

Apr 24, 2025 at 8:30 AM EDT · Issued by Sun Pharmaceutical Industries Limited

Filed with NSE · Apr 24, 2025 at 8:30 AM EDT

On 6ix: 6ix.com/news/press-release-apr-24-2025-4

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated April 24, 2025

View Attachment

6ix hasn’t read this filing yet.

Sun Pharmaceutical Industries Limited on 6ix

Earlier from Sun Pharmaceutical Industries

  • Press Release Apr 07 2025Apr 7, 2025
  • Press Release Feb 17 2025Feb 17, 2025
  • Press Release Feb 04 2025Feb 4, 2025
  • Sun Pharma Presents LEQSELVI Data Highlighting Clinical Efficacy and Durability for Treatment of Alopecia Areata at the 2024 Fall Clinical Dermatology ConferenceOct 28, 2024
  • Press Release Oct 25 2024Oct 25, 2024

Later from Sun Pharmaceutical Industries

  • Sun Pharma and Moebius Medical Announce Dual Publications on MM-II's Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and CartilageApr 25, 2025
  • Press Release May 08 2025May 8, 2025
  • Press Release May 12 2025May 12, 2025
  • Press Release May 16 2025May 16, 2025
  • Press Release May 30 2025May 30, 2025
All Sun Pharmaceutical Industries news releases↗

Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.

Follow Sun Pharmaceutical Industries
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer